BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
Lorenzo Bertani 1
Luca Antonioli 1
Marco Fornili 1
Vanessa D'Antongiovanni 1
Francesca Coppini 1
Ceccarelli Linda 2
Laura Benvenuti 1
Maria Gloria Mumolo 2
Laura Baglietto 1
Massimo Bellini 1
Matteo Fornai 1
Nicola De Bortoli 1
Francesco Costa 2
1 University of Pisa, Pisa, Italy
2 Pisa University Hospital, Pisa, Italy
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]